SIRT2 and early-onset autosomal dominant Alzheimer disease: First, the specific SIRT2 inhibitor AK-1, which is actively being evaluated in Alzheimer’s disease models, was used to inhibit HIV replication in PHA-activated T cells and monocyte-derived macrophages (MDMs) infected in vitro with different HIV strains.